POSTER SESSION V
Wednesday, March 28, 2007   9:30 AM - 12:00 Noon
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
GASTROINTESTINAL PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
47
Reduced Immunoexpression of O6-Methylguanine-DNA Methyltransferase in Inflammatory Bowel Disease -Associated and Sporadic Serrated Polyps
(546)
Q Liu, A Khramtsov, M Tretiakova, J Hart, A Noffsinger - The University of Chicago Hospitals, Chicago, IL
Immunohistochemical Characterization of Serrated Lesions in Inflammatory Bowel Disease
(490)
VS Chandan, TC Smyrk, SC Abraham - Mayo Clinic, Rochester, MN
Histologic Features That Distinguish Sessile Serrated Adenomas and Hyperplastic Polyps Are Related to Polyp Size: Smaller Polyps Merge into a Single Morphologic Entity
(485)
D Bosler, NS Goldstein - William Beaumont Hospital, Royal Oak, MI
Expanding the Spectrum of Sessile Serrated Adenoma
(495)
SM Chung, Y-T Chen, A Panczykowski, DS Klimstra, RK Yantiss - Weill Medical College, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY
Serrated Polyp Neoplasia Pathway Histological Categories in the National Polyp Study
(558)
MJ O’Brien, AG Zauber, SJ Winawer, CL Shepherd, SS Sternberg, LS Gottlieb, JH Bond, JD Waye, M Schapiro - Boston University School of Medicine, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY
sFRP-1 and Maspin Immunohistochemistry of Serrated Colorectal Polyps with Abnormal Proliferation
(517)
D Gray, E Solomon, M Evans, A Hartmann, K Cooper, H Blaszyk - University of Vermont, College of Medicine, Burlington, VT; University of Regensburg, Regensburg, Germany
Cytokeratin 7 and CDX2 Immunolabeling Reliably Distinguishes Serrated Polyps of the Colorectum with and without Neoplastic Potential
(594)
JM Wu, CA Iacobuzio-Donahue - Johns Hopkins Medical Institutions, Baltimore, MD
Colorectal Adenomas with Mixed Conventional and Serrated Adenomatous Features: A Clinicopathologic and Immunophenotypic Study of 15 Cases
(575)
M Redston, H Hahn, RD Odze - - Brigham and Women’s Hospital, Boston, MA
Morphologic Features of High-Grade Serrated Dysplasia in Sessile Serrated Adenomas without Coexistent Invasive Adenocarcinoma
(513)
NS Goldstein - - William Beaumont Hospital, Royal Oak, MI
Molecular Features of Serrated Epithelial Lesions of the Appendix
(595)
RK Yantiss, HP Hahn, RD Odze, YT Chen - Weill Cornell Medical College, New York, NY; Brigham & Women’s Hospital, Boston, MA
Serrated Epithelial Proliferations of the Appendix
(584)
A Sepehr, AJ Iafrate, GY Lauwers, J Misdraji - Massachusetts General Hospital and Harvard Medical School, Boston, MA
Is There Uniformity in the Diagnosis of High Grade Dysplasia in Adenomatous Colon Polyps?
(496)
OW Cummings, SC Chen, JR Goldblum, MJ O’Brien, R Ridell, A Mouchli, V Chadalawada, TM Ulbright, DK Rex - Indiana U School of Medicine, Indianapolis, IN; Cleveland Clinic, Cleveland, OH; Boston University Medical Center, Boston, MA; Mount Sinai Hospital, Toronto, ON, Canada
Pathologic Features of Carcinomas in Patients with MYH Associated Polyposis
(559)
AM O’ Shea, RH Riddell, A Pollett, S Gallinger - Mount Sinai Hospital, Toronto, Canada; Mount Sinai Hospital, Toronto, ON, Canada
Lymphatic Permeation Demonstrated in Minimally Invasive Colonic Adenocarcinomas
(479)
S Ban, F Ogawa, Y Shimizu, M Shimizu - Saitama Medical University School of Medicine, Moroyama, Iruma, Saitama, Japan
Lymphovascular Invasion in Colorectal Cancer: An Interobserver Variability Study
(533)
EI Johnston, DN Lewin, HL Wang, GY Lauwers, A Srivastava, Y Shyr, MK Washington - Vanderbilt University, Nashville, TN; MUSC Medical Center, Charleston, SC; Washington University, St. Louis, St. Louis, MO; Harvard Medical School, Massachusetts General Hospital, Boston, MA
Histological Charactestics Predictive of Nodal Metastasis in T1 Colorectal Carcinoma
(476)
F Arif, M Dardik - - Saint Barnabas Medical Center, Livingston, NJ
Primary Colorectal Small Cell Carcinoma: A Clinico-Pathological and Immunohistochemical Study of 9 Cases
(507)
D El Demellawy, Z Ghorab, N Ismiil, MA Khalifa - - University of Toronto, Toronto, ON, Canada
Routine Use of Immunohistochemistry for the Mismatch Repair Proteins on Unselected CRC: An Initial Experience
(596)
MM Yearsley, H Hampel, WL Marsh, SS Cook, WL Frankel - The Ohio State University Medical Center, Columbus, OH
Tissue Microarrays Provide a Cost-Effective Method for Screening Colorectal Carcinomas for Lynch Syndrome
(475)
S Alam, H Hampel, M Bloomston, J LaJeunesse, A de la Chapelle, WL Frankel - Ohio State University, Columbus, OH
p16 Expression Is Associated with Familial Status in MLH1-Deficient Colorectal Carcinomas
(570)
A Paya, C Alenda, S Benlloch, R Jover, G Peiro, FI Aranda - Hospital General Universitario de Alicante, Alicante, Spain
Validation of Morphologic Predictors of Microsatellite Instability in Colorectal Cancer
(518)
JK Greenson, G Rennert, S Presswala, M Low, LS Rozek, JD Bonner, LP Thomsho, SB Gruber - University of Michigan, Ann Arbor, MI; Carmel Medical Center, Technion Faculty of Medicine and CHS National Cancer Control Center, Haifa, Israel
Do Histopathologic Features of Colorectal Carcinoma Predict Microsatellite Instability or CpG Island Methylator Phenotype or Both?
(564)
S Ogino, M Loda, CS Fuchs - Brigham and Women’s Hosp, Boston, MA; Dana-Farber Cancer Inst, Boston, MA; Harvard Medical School, Boston, MA
A Large Population-Based Colorectal Cancer Sample Shows Correlations of CpG Island Methylator Phenotype-Low with Male Sex and KRAS Mutations
(563)
S Ogino, T Kawasaki, M Loda, CS Fuchs - Brigham and Women[apos]s Hosp, Boston, MA; Dana-Farber Cancer Inst, Boston, MA; Harvard Medical School, Boston, MA
CpG Island Methylator Phenotype in Microsatellite Stable Colorectal Cancers; Differences between Existing CIMP and Newly Described CIMP
(540)
S Lee, SY Park, JH Kim, NY Cho, MH Choi, EJ Yoo, GH Kang - School of Medicine, Kyung Hee University, Seoul, Republic of Korea; Seoul National University College of Medicine, Seoul, Republic of Korea
Decreased CK20 Expression in MGMT-Deficient Colorectal Carcinomas: Evidence of a Distinct Phenotypic Association
(511)
JA Gibson, GP Bailey, M Redston, JL Hornick - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA